Abd EL Fattah YK, Abulsoud AI, Abdelhamid SG, Abdelhalim S, Hamdy NM (2023) CCDC144NL-AS1/hsa-miR-143-3p/HMGA2 interaction: In-silico and clinically implicated in CRC progression, correlated to tumor stage and size in case-controlled study; step toward ncRNA precision. Intl J Biol Macromol 253:126739

Abraham SA, Waterhouse DN, Mayer LD, Cullis PR, Madden TD, Bally MB (2005) The liposomal formulation of doxorubicin. Methods in enzymology. Elsevier

Akbari Kordkheyli V, Rashidi M, Shokri Y, Fallahpour S, Variji A, Bazi A, Nabipour Ghara E, Hosseini SM (2021) CRISPER/CAS system, a novel tool of targeted therapy of drug-resistant lung cancer. Adv Pharmaceut Bull 12:262–273

Google Scholar 

Al-Malky HS, Al Harthi SE, Osman A-MM (2020) Major obstacles to doxorubicin therapy: Cardiotoxicity and drug resistance. J Oncol Pharm Prac 26:434–444

Article  Google Scholar 

Alizadeh MN, Rashidi M, Muhammadnejad A, Zanjani TM, Ziai SA (2018) Antitumor effects of umbelliprenin in a mouse model of colorectal cancer. Iranian J Pharmaceut Res: IJPR 17:976

CAS  Google Scholar 

Asefy Z, Tanomand A, Hoseinnejhad S, Ceferov Z, Oshaghi EA, Rashidi M (2021) Unsaturated fatty acids as a co-therapeutic agents in cancer treatment. Mol Biol Rep 48:2909–2916

Article  PubMed  CAS  Google Scholar 

Autin P, Blanquart C, Fradin D (2019) Epigenetic drugs for cancer and microRNAs: a focus on histone deacetylase inhibitors. Cancers 11:1530

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bagheri A, Khorshid HRK, Tavallaie M, Mowla SJ, Sherafatian M, Rashidi M, Zargari M, Boroujeni ME, Hosseini SM (2019) A panel of noncoding RNAs in non–small-cell lung cancer. J Cell Biochem 120:8280–8290

Article  PubMed  CAS  Google Scholar 

Bai H, Wei J, Deng C, Yang X, Wang C, Xu R (2013) MicroRNA-21 regulates the sensitivity of diffuse large B-cell lymphoma cells to the CHOP chemotherapy regimen. Int J Hematol 97:223–231

Article  PubMed  CAS  Google Scholar 

Benassi B, Marani M, Loda M, Blandino G (2013) USP2a alters chemotherapeutic response by modulating redox. Cell Death Dis 4:e812–e812

Article  PubMed  PubMed Central  CAS  Google Scholar 

Cañas JA, Rodrigo-Muñoz JM, Sastre B, Gil-Martinez M, Redondo N, del Pozo V (2021) MicroRNAs as potential regulators of immune response networks in asthma and chronic obstructive pulmonary disease. Front Immunol 11:608666

Article  PubMed  PubMed Central  Google Scholar 

Canatan D (2020) The impact of MicroRNAs (miRNAs) on the genotype of coronaviruses. Acta Bio Medica: Atenei Parmensis 91:195

PubMed  CAS  Google Scholar 

Carta A, Chetcuti R, Ayers D (2014) An introspective update on the influence of miRNAs in breast carcinoma and neuroblastoma chemoresistance. Genetics Res Intl, 2014

Carvalho C, Santos RX, Cardoso S, Correia S, Oliveira PJ, Santos MS, Moreira PI (2009) Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem 16:3267–3285

Article  PubMed  CAS  Google Scholar 

Chen D, Yan W, Liu Z, Zhang Z, Zhu L, Liu W, Ding X, Wang A, Chen Y (2016a) Downregulation of miR-221 enhances the sensitivity of human oral squamous cell carcinoma cells to Adriamycin through upregulation of TIMP3 expression. Biomed Pharmacother 77:72–78

Article  PubMed  CAS  Google Scholar 

Chen J, Zhou C, Li J, Xiang X, Zhang L, Deng J, Xiong J (2018) miR-21-5p confers doxorubicin resistance in gastric cancer cells by targeting PTEN and TIMP3. Int J Mol Med 41:1855–1866

PubMed  PubMed Central  CAS  Google Scholar 

Chen X, Wang YW, Xing AY, Xiang S, Shi DB, Liu L, Li YX, Gao P (2016b) Suppression of SPIN1-mediated PI3K–Akt pathway by miR-489 increases chemosensitivity in breast cancer. J Pathol 239:459–472

Article  PubMed  CAS  Google Scholar 

Chowdhury SG, Ray R, Karmakar P (2023) Exosomal miRNAs—a diagnostic biomarker acting as a guiding light in the diagnosis of prostate cancer. Funct Integr Genomics 23:23

Article  CAS  Google Scholar 

Chu S, Liu G, Xia P, Chen G, Shi F, Yi T, Zhou H (2017) miR-93 and PTEN: Key regulators of doxorubicin-resistance and EMT in breast cancer. Oncol Rep 38:2401–2407

Article  PubMed  CAS  Google Scholar 

Congras A, Caillet N, Torossian N, Quelen C, Daugrois C, Brousset P, Lamant L, Meggetto F, Hoareau-Aveilla C (2018) Doxorubicin-induced loss of DNA topoisomerase II and DNMT1-dependent suppression of MiR-125b induces chemoresistance in ALK-positive cells. Oncotarget 9:14539

Article  PubMed  PubMed Central  Google Scholar 

Dai H, Xu L-Y, Qian Q, Zhu Q-W, Chen W-X (2019) MicroRNA-222 promotes drug resistance to doxorubicin in breast cancer via regulation of miR-222/bim pathway. Biosci Reports, 39

Deng Y, Bai H, Hu H (2015) rs11671784 G/A variation in miR-27a decreases chemo-sensitivity of bladder cancer by decreasing miR-27a and increasing the target RUNX-1 expression. Biochem Biophys Res Commun 458:321–327

Article  PubMed  CAS  Google Scholar 

Ding Q, He K, Luo T, Deng Y, Wang H, Liu H, Zhang J, Chen K, Xiao J, Duan X (2016) SSRP1 contributes to the malignancy of hepatocellular carcinoma and is negatively regulated by miR-497. Mol Ther 24:903–914

Article  PubMed  PubMed Central  CAS  Google Scholar 

Doghish AS, Hegazy M, Ismail A, EL-Mahdy HA, Elsakka EG, Elkhawaga SY, Elkady MA, Yehia AM, Abdelmaksoud NM, Mokhtar MM (2023) A spotlight on the interplay of signaling pathways and the role of miRNAs in osteosarcoma pathogenesis and therapeutic resistance. Pathol Res Prac, 154442

Dong Z, Lei Q, Yang R, Zhu S, Ke X-X, Yang L, Cui H, Yi L (2017) Inhibition of neurotensin receptor 1 induces intrinsic apoptosis via let-7a-3p/Bcl-w axis in glioblastoma. Br J Cancer 116:1572–1584

Article  PubMed  PubMed Central  CAS  Google Scholar 

Donzelli S, Fontemaggi G, Fazi F, di Agostino S, Padula F, Biagioni F, Muti P, Strano S, Blandino G (2012) MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function. Cell Death Differ 19:1038–1048

Article  PubMed  CAS  Google Scholar 

Du L, Ma S, Wen X, Chai J, Zhou D (2017) Oral squamous cell carcinoma cells are resistant to doxorubicin through upregulation of miR-221. Mol Med Rep 16:2659–2667

Article  PubMed  PubMed Central  CAS  Google Scholar 

El-Aziz MKA, Dawoud A, Kiriacos CJ, Fahmy SA, Hamdy NM, Youness RA (2023) Decoding hepatocarcinogenesis from a noncoding RNAs perspective. J Cell Physiol 238:1982–2009

Article  PubMed  CAS  Google Scholar 

Emam O, Wasfey EF, Hamdy NM (2022) Notch-associated lncRNAs profiling circuiting epigenetic modification in colorectal cancer. Cancer Cell Int 22:316

Article  PubMed  PubMed Central  CAS  Google Scholar 

Entezari M, Sadrkhanloo M, Rashidi M, Asnaf SE, Taheriazam A, Hashemi M, Ashrafizadeh M, Zarrabi A, Rabiee N, Hushmandi K (2022) Non-coding RNAs and macrophage interaction in tumor progression. Critical Reviews in Oncology/Hematology, 103680

Fang Y, Shen H, Cao Y, Li H, Qin R, Chen Q, Long L, Zhu X, Xie C, Xu W (2014) Involvement of miR-30c in resistance to doxorubicin by regulating YWHAZ in breast cancer cells. Braz J Med Biol Res 47:60–69

Article  PubMed  PubMed Central  CAS  Google Scholar 

Faskhoudi MA, Molaei P, Sadrkhanloo M, Orouei S, Hashemi M, Bokaie S, Rashidi M, Entezari M, Zarrabi A, Hushmandi K (2022) Molecular landscape of c-Myc signaling in prostate cancer: A roadmap to clinical translation. Pathol Res Prac, 153851

Fathi D, Elballal MS, Elesawy AE, Abulsoud AI, Elshafei A, Elsakka EG, Ismail A, El-Mahdy HA, Elrebehy MA, Doghish AS (2023) An emphasis on the interaction of signaling pathways highlights the role of miRNAs in the etiology and treatment resistance of gastric cancer. Life Sci, 121667

Fattahi M, Rezaee D, Fakhari F, Najafi S, Aghaei-Zarch SM, Beyranvand P, Rashidi MA, Bagheri-Mohammadi S, Zamani-Rarani F, Bakhtiari M (2023) microRNA-184 in the landscape of human malignancies: a review to roles and clinical significance. Cell Death Discovery 9:423

Article  PubMed  PubMed Central  CAS  Google Scholar 

Feng R, Dong L (2015) Knockdown of microRNA-127 reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human glioma cells. Int J Clin Exp Pathol 8:6107

PubMed  PubMed Central  Google Scholar 

Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L, Gramantieri L (2010) MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Can Res 70:5184–5193

Article  CAS  Google Scholar 

Gao X, Wang M, Zhang Y, Xu Z, Ding J, Tang J (2019) MicroRNA-16 sensitizes drug-resistant breast cancer cells to Adriamycin by targeting Wip1 and Bcl-2. Oncol Lett 18:2897–2906

PubMed  PubMed Central  CAS  Google Scholar 

Giunti L, da Ros M, Vinci S, Gelmini S, Iorio AL, Buccoliero AM, Cardellicchio S, Castiglione F, Genitori L, de Martino M (2015) Anti-miR21 oligonucleotide enhances chemosensitivity of T98G cell line to doxorubicin by inducing a